Literature DB >> 27807064

Mechanisms and Targets Involved in Dissemination of Ovarian Cancer.

Ulrich H Weidle1, Fabian Birzele2, Gwendlyn Kollmorgen1, Rüdiger Rueger3.   

Abstract

Ovarian carcinoma is associated with the highest death rate of all gynecological tumors. On one hand, its aggressiveness is based on the rapid dissemination of ovarian cancer cells to the peritoneum, the omentum, and organs located in the peritoneal cavity, and on the other hand, on the rapid development of resistance to chemotherapeutic agents. In this review, we focus on the metastatic process of ovarian cancer, which involves dissemination of, homing to and growth of tumor cells in distant organs, and describe promising molecular targets for possible therapeutic intervention. We provide an outline of the interaction of ovarian cancer cells with the microenvironment such as mesothelial cells, adipocytes, fibroblasts, endothelial cells, and other stromal components in the context of approaches for therapeutic interference with dissemination. The targets described in this review are discussed with respect to their validity as drivers of metastasis and to the availability of suitable efficient agents for their blockage, such as small molecules, monoclonal antibodies or antibody conjugates as emerging tools to manage this disease. Copyright
© 2016, International Institute of Anticancer Research (Dr. John G. Delinasios), All rights reserved.

Entities:  

Keywords:  Adipocytes; EOC; ascites; epithelial ovarian cancer Penzberg; growth of metastases; homing; mesothelial cells; peritoneal cells; review; therapeutic targets; transcoelomic dissemination

Mesh:

Substances:

Year:  2016        PMID: 27807064      PMCID: PMC5219915          DOI: 10.21873/cgp.20004

Source DB:  PubMed          Journal:  Cancer Genomics Proteomics        ISSN: 1109-6535            Impact factor:   4.069


  154 in total

Review 1.  Hyaluronan: from extracellular glue to pericellular cue.

Authors:  Bryan P Toole
Journal:  Nat Rev Cancer       Date:  2004-07       Impact factor: 60.716

2.  Fractalkine receptor CX(3)CR1 is expressed in epithelial ovarian carcinoma cells and required for motility and adhesion to peritoneal mesothelial cells.

Authors:  Mijung Kim; Lisa Rooper; Jia Xie; Andre A Kajdacsy-Balla; Maria V Barbolina
Journal:  Mol Cancer Res       Date:  2011-11-07       Impact factor: 5.852

Review 3.  Apoptosis and chemoresistance in human ovarian cancer: is Xiap a determinant?

Authors:  J Li; H Sasaki; Y L Sheng; D Schneiderman; C W Xiao; F Kotsuji; B K Tsang
Journal:  Biol Signals Recept       Date:  2000 Mar-Apr

4.  Differential gene expression in ovarian carcinoma: identification of potential biomarkers.

Authors:  Kathleen Hibbs; Keith M Skubitz; Stefan E Pambuccian; Rachael C Casey; Kathryn M Burleson; Theodore R Oegema; Jeannine J Thiele; Suzanne M Grindle; Robin L Bliss; Amy P N Skubitz
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

5.  Interplay of human tissue kallikrein 4 (hK4) with the plasminogen activation system: hK4 regulates the structure and functions of the urokinase-type plasminogen activator receptor (uPAR).

Authors:  Nathalie Beaufort; Mekdes Debela; Sabine Creutzburg; Josef Kellermann; Wolfram Bode; Manfred Schmitt; Dominique Pidard; Viktor Magdolen
Journal:  Biol Chem       Date:  2006-02       Impact factor: 3.915

Review 6.  Multicellular spheroids in ovarian cancer metastases: Biology and pathology.

Authors:  Kristy Shield; M Leigh Ackland; Nuzhat Ahmed; Gregory E Rice
Journal:  Gynecol Oncol       Date:  2009-01-10       Impact factor: 5.482

Review 7.  c-Met as a Target for Personalized Therapy.

Authors:  Ingrid Garajová; Elisa Giovannetti; Guido Biasco; Godefridus J Peters
Journal:  Transl Oncogenomics       Date:  2015-11-23

8.  Identification of ovarian cancer metastatic miRNAs.

Authors:  Souriya Vang; Hsin-Ta Wu; Andrew Fischer; Daniel H Miller; Shannon MacLaughlan; Elijah Douglass; Lauren Comisar; Margaret Steinhoff; Colin Collins; Peter J S Smith; Laurent Brard; Alexander S Brodsky
Journal:  PLoS One       Date:  2013-03-12       Impact factor: 3.240

Review 9.  Exosomes: an overview of biogenesis, composition and role in ovarian cancer.

Authors:  Allison Beach; Huang-Ge Zhang; Mariusz Z Ratajczak; Sham S Kakar
Journal:  J Ovarian Res       Date:  2014-01-25       Impact factor: 4.234

Review 10.  Tumor-associated macrophages contribute to tumor progression in ovarian cancer.

Authors:  Emily K Colvin
Journal:  Front Oncol       Date:  2014-06-06       Impact factor: 6.244

View more
  45 in total

1.  Migration dynamics of ovarian epithelial cells on micro-fabricated image-based models of normal and malignant stroma.

Authors:  Samuel Alkmin; Rebecca Brodziski; Haleigh Simon; Daniel Hinton; Randall H Goldsmith; Manish Patankar; Paul J Campagnola
Journal:  Acta Biomater       Date:  2019-09-27       Impact factor: 8.947

Review 2.  Potential microRNA-related Targets for Therapeutic Intervention with Ovarian Cancer Metastasis.

Authors:  Ulrich H Weidle; Fabian Birzele; Gwen Kollmorgen; Adam Nopora
Journal:  Cancer Genomics Proteomics       Date:  2018 Jan-Feb       Impact factor: 4.069

3.  UNBS5162 inhibits SKOV3 ovarian cancer cell proliferation by regulating the PI3K/AKT signalling pathway.

Authors:  Qiang Wang; Wei Shi
Journal:  Oncol Lett       Date:  2019-01-04       Impact factor: 2.967

4.  Fast and Durable Intraoperative Near-infrared Imaging of Ovarian Cancer Using Ultrabright Squaraine Fluorophores.

Authors:  Takeshi Fukuda; Shinya Yokomizo; Stefanie Casa; Hailey Monaco; Sophia Manganiello; Haoran Wang; Xiangmin Lv; Amy Daniel Ulumben; Chengeng Yang; Min-Woong Kang; Kazumasa Inoue; Masahiro Fukushi; Toshiyuki Sumi; Cheng Wang; Homan Kang; Kai Bao; Maged Henary; Satoshi Kashiwagi; Hak Soo Choi
Journal:  Angew Chem Int Ed Engl       Date:  2022-02-26       Impact factor: 15.336

Review 5.  The senescence-associated secretory phenotype in ovarian cancer dissemination.

Authors:  Jacob P Veenstra; Lucas Felipe Fernandes Bittencourt; Katherine M Aird
Journal:  Am J Physiol Cell Physiol       Date:  2022-05-18       Impact factor: 5.282

6.  Multisite Tumor Sampling Reveals Extensive Heterogeneity of Tumor and Host Immune Response in Ovarian Cancer.

Authors:  Sotirios Lakis; Vassiliki Kotoula; Georgia-Angeliki Koliou; Ioannis Efstratiou; Sofia Chrisafi; Alexios Papanikolaou; Pantelis Zebekakis; George Fountzilas
Journal:  Cancer Genomics Proteomics       Date:  2020 Sep-Oct       Impact factor: 4.069

7.  The Influence of the Preoperative Status on the Risk of Postoperative Complications After Cytoreductive Surgery for Advanced-stage Ovarian Cancer.

Authors:  Laura Iliescu; Camelia Diaconu; Nicolae Bacalbasa; Irina Balescu; Mihai Dimitriu; Simona Dima; Mihaela Vilcu; Iulian Brezean
Journal:  In Vivo       Date:  2020 Mar-Apr       Impact factor: 2.155

8.  Axillary lymph node metastasis in ovarian carcinoma: Two case reports and review of literature.

Authors:  Ram Eitan; Daliah Tsoref; Gad Sabah; Lina Salman
Journal:  Gynecol Oncol Rep       Date:  2017-11-14

9.  Human Epididymis Protein 4 Promotes Events Associated with Metastatic Ovarian Cancer via Regulation of the Extracelluar Matrix.

Authors:  Jennifer R Ribeiro; Hilary M Gaudet; Mehreen Khan; Christoph Schorl; Nicole E James; Matthew T Oliver; Paul A DiSilvestro; Richard G Moore; Naohiro Yano
Journal:  Front Oncol       Date:  2018-01-22       Impact factor: 6.244

10.  Wilms' tumor 1 (WT1) promotes ovarian cancer progression by regulating E-cadherin and ERK1/2 signaling.

Authors:  Yun Han; Chao Song; Tingting Zhang; Qianqian Zhou; Xiaoqian Zhang; Jing Wang; Boqun Xu; Xuesen Zhang; Xiaoqiu Liu; Xiaoyan Ying
Journal:  Cell Cycle       Date:  2020-09-07       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.